Nuclear remodelling: a consequence of nucleocytoplasmic traffic run amok?
Nuclear remodelling: a consequence of nucleocytoplasmic traffic run amok?
复制标题
核重塑:核质运输失控的结果?
DOI:
10.1093/cvr/cvu252
复制
发表时间:
2015
影响因子:
10.8
通讯作者:
Bossuyt,Julie
中科院分区:
文献类型:
--
作者:
Bossuyt,Julie
An intriguing new study by Chahineet al. 1 finds that alterations in nuclear architecture and transport machinery (leading to increased export and decreased import) manifest early on, during hypertrophy development, in both a rat infarct model and human failing hearts. Moreover, it finds that general blockade of the increased nuclear export traffic can prevent or even reverse both the nuclear remodelling and hypertrophic changes. This article forwards the interesting notion that failure of the nuclear import/export pathways themselves is at the basis of the nuclear remodelling process during heart failure development. Cardiac remodelling is a hallmark of heart failure characterized at the myocyte level by cellular hypertrophy and reactivation of a fetal gene program. Studies examining the molecular mechanisms underlying the transcriptional reprogramming typically focus on the interwoven signalling cascades that culminate in the nucleus (eg NFAT-and HDAC-dependent pathways). A critical step in the transcriptional regulation here is the nucleocytoplasmic trafficking of key signalling components through the nuclear pore (Figure 1). Chahine et al., however, embarked on their study from an interesting traffic planning perspective: how does increased traffic demand induced by hypertrophic stimuli impact traffic speeds (congestion) and infrastructure of the nuclear transit pathway (road capacity and traffic regulation)? Although accumulating evidence indicates several transport mechanisms could operate on the same signal molecule in parallel, 2 Chahine et al. constrained themselves to investigating alterations in the classical import and export pathways involving importins and exportins. They show decreased expression of nucleoporin p62, importins (a and b), and cytoplasmic RanBP1 (ie reduced docking and driving force for nuclear import) and an increase in exportin-1 expression and translocation (ie increased docking and translocation for nuclear export) in various hypertrophic models. Their nuclear protein import assay also indicates a reduction in both magnitude and transport rate of the nuclear import pathway. The model proposed by Chahine et al. is that in order to sustain the increased nuclear export necessary for the increase de novo protein synthesis during hypertrophy, the nuclear import must be decreased (a reciprocal shift)(Figure 1 B). That is the increased asymmetric traffic demand is satisfied by drafting existing lanes for nuclear export, a reversible lane system. Their observations however are not inconsistent with alternate traffic coping mechanisms operating in parallel (Figure 1 C) such as an increase in road capacity or altered traffic management (eg bottleneck modification, expansion of transport modalities, creation of express lanes, preferential road users). The existence of such parallel coping mechanisms is certainly plausible given the observations of altered nuclear pore composition and function in heart failure, 3–5 importin/exportin-independent nuclear trafficking, 2 and nuclear accumulation of specific hypertrophic signal transducers (eg HDAC kinases, NFATs). 6, 7 Further study is needed to distinguish between these different traffic models and to determine whether similar trafficking changes would be observed in different pathophysiological conditions or pharmacological responses. 8 Chahine et al. also propose that transcriptional strategies for heart failure treatment might successfully target the nucleocytoplasmic trafficking process itself rather than the trafficked cargo. They do find clear evidence that the rearrangement of nuclear transport machinery and function is altered early on during the hypertrophic phase of their rat infarct …